Smart labels for drugs and medical devices, both after commercial launch and during clinical trials, do far more than simply identify a product; their built-in intelligence provides functionality, communication capabilities, and interactivity throughout the supply chain all the way to the end-user.

Featuring technology ranging from simple chemical-based visual indicators to more-cutting-edge radio frequency identification (RFID) and near field communication (NFC), today’s smart labels play a growing role in maintaining brand security, improving supply chains, improving the accuracy of clinical trials, connecting consumers to brand owners, gathering marketing intelligence, and ensuring consumer safety.

The benefits and advantages of smart labels will be discussed further in this white paper.

 

Register below to download the White Paper.